0001883850-22-000022.txt : 20220330
0001883850-22-000022.hdr.sgml : 20220330
20220330164209
ACCESSION NUMBER: 0001883850-22-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220328
FILED AS OF DATE: 20220330
DATE AS OF CHANGE: 20220330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 22787103
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-03-28
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
Common Stock
2022-03-28
4
M
0
1250
555.67
A
29994
D
Common Stock
2022-03-28
4
F
0
1134
685.26
D
28860
D
Common Stock
2022-03-28
4
M
0
1250
555.67
A
30110
D
Common Stock
2022-03-28
4
F
0
1134
685.26
D
28976
D
Common Stock
2022-03-28
4
M
0
4000
399.66
A
32976
D
Common Stock
2022-03-28
4
F
0
3183
685.26
D
29793
D
Common Stock
2022-03-28
4
M
0
4500
399.66
A
34293
D
Common Stock
2022-03-28
4
F
0
3581
685.26
D
30712
D
Common Stock
2022-03-28
4
M
0
3500
399.66
A
34212
D
Common Stock
2022-03-28
4
F
0
2785
685.26
D
31427
D
Common Stock
2022-03-29
4
S
0
54
681.9
D
31373
D
Common Stock
2022-03-29
4
S
0
103
682.37
D
31270
D
Common Stock
2022-03-29
4
S
0
304
683.29
D
30966
D
Common Stock
2022-03-29
4
S
0
227
684.45
D
30739
D
Common Stock
2022-03-29
4
S
0
176
685.58
D
30563
D
Common Stock
2022-03-29
4
S
0
192
686.67
D
30371
D
Common Stock
2022-03-29
4
S
0
220
687.52
D
30151
D
Common Stock
2022-03-29
4
S
0
542
688.55
D
29609
D
Common Stock
2022-03-29
4
S
0
205
689.33
D
29404
D
Common Stock
2022-03-29
4
S
0
37
690.91
D
29367
D
Common Stock
2022-03-29
4
S
0
226
691.47
D
29141
D
Common Stock
2022-03-29
4
S
0
147
692.38
D
28994
D
Common Stock
2022-03-29
4
S
0
103
693.18
D
28891
D
Common Stock
2022-03-29
4
S
0
147
694.94
D
28744
D
Common Stock
229
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
399.66
2022-03-28
4
M
0
4000
0.0
D
2024-12-16
Common Stock
4000
13000
D
Non-Qualified Stock Option (right to buy)
399.66
2022-03-28
4
M
0
4500
0.0
D
2024-12-16
Common Stock
4500
8500
D
Non-Qualified Stock Option (right to buy)
399.66
2022-03-28
4
M
0
3500
0.0
D
2024-12-16
Common Stock
3500
5000
D
Non-Qualified Stock Option (right to buy)
555.67
2022-03-28
4
M
0
1250
0.0
D
2025-12-16
Common Stock
1250
1250
D
Non-Qualified Stock Option (right to buy)
555.67
2022-03-28
4
M
0
1250
0.0
D
2025-12-16
Common Stock
1250
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 54 shares of Company stock on March 29, 2022 at prices ranging from $681.89 to $681.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 103 shares of Company stock on March 29, 2022 at prices ranging from $682.09 to $682.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 304 shares of Company stock on March 29, 2022 at prices ranging from $683.06 to $683.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 227 shares of Company stock on March 29, 2022 at prices ranging from $684.02 to $684.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 176 shares of Company stock on March 29, 2022 at prices ranging from $685.09 to $685.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 192 shares of Company stock on March 29, 2022 at prices ranging from $686.06 to $686.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 220 shares of Company stock on March 29, 2022 at prices ranging from $687.08 to $687.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 542 shares of Company stock on March 29, 2022 at prices ranging from $688.00 to $688.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 205 shares of Company stock on March 29, 2022 at prices ranging from $689.05 to $689.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 37 shares of Company stock on March 29, 2022 at prices ranging from $690.77 to $690.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 226 shares of Company stock on March 29, 2022 at prices ranging from $691.16 to $691.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 147 shares of Company stock on March 29, 2022 at prices ranging from $692.18 to $692.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
Represents volume-weighted average price of sales of 103 shares of Company stock on March 29, 2022 at prices ranging from $693.01 to $693.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 29, 2022 at each separate price.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert E. Landry
2022-03-30